EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLE ORGANISATION DATE TOPIC
EMA clarifies no scientific evidence to deter use of ibuprofen to manage coronavirus symptoms Medicines for Europe 18 Mar 2020 Health & Consumers
Medicines for Europe statement on COVID-19 (‘coronavirus’) Medicines for Europe 13 Mar 2020 Health & Consumers
Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy Medicines for Europe 03 Mar 2020 Health & Consumers
The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe Medicines for Europe 07 Feb 2020 Health & Consumers, InfoSociety
Time to modernise the eu pharmaceutical regulatory framework to deliver on access Medicines for Europe 30 Jan 2020 Health & Consumers, InfoSociety
Smart Pharmacovigilance Essential for Patient Safety Medicines for Europe 29 Jan 2020 Health & Consumers
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe Medicines for Europe 28 Nov 2019 Health & Consumers
‘Health revolution’: when smart innovation benefits patients Medicines for Europe 21 Nov 2019 Health & Consumers
Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal Medicines for Europe 14 Nov 2019 Health & Consumers
Biosimilar medicines: competition, sustainability and early* access on the agenda of DG GROW stakeholder workshop Medicines for Europe 30 Oct 2019 Health & Consumers
Report identifies 9 key ingredients to improve access to medicines in the hospital setting Medicines for Europe 08 Oct 2019 Health & Consumers
EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement Medicines for Europe 30 Sep 2019 Health & Consumers
Immediately calls on new President of EU Commission to prioritise Healthcare Medicines for Europe 25 Sep 2019 Health & Consumers, InfoSociety
A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector Medicines for Europe 24 Sep 2019 Health & Consumers
Ready to drive access to medicines Medicines for Europe 24 Jul 2019 Health & Consumers
‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access Medicines for Europe 03 Apr 2019 Health & Consumers
New safeguards for patient safety as Falsified Medicines Directive comes into force Medicines for Europe 11 Feb 2019 Health & Consumers
SPC manufacturing waiver cannot be derailed by foreign vested interests Medicines for Europe 07 Feb 2019 Health & Consumers
Efficient use of pharmacovigilance data essential for patient safety Medicines for Europe 30 Jan 2019 Health & Consumers
Competition policy essential for access to medicines Medicines for Europe 29 Jan 2019 Health & Consumers
Crucial European Parliament vote vastly improves SPC manufacturing waiver Medicines for Europe 24 Jan 2019 Health & Consumers
Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver! Medicines for Europe 04 Dec 2018 Health & Consumers
Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines. Medicines for Europe 30 Nov 2018 Health & Consumers
Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI). Medicines for Europe 28 Nov 2018 Health & Consumers
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines Medicines for Europe 26 Nov 2018 Health & Consumers
Value added medicines: Continuous innovation crucial to improve healthcare across Europe Medicines for Europe 21 Nov 2018 Health & Consumers
Driving local excellence, delivering European results Medicines for Europe 06 Nov 2018 Health & Consumers
US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver Medicines for Europe 22 Oct 2018 Health & Consumers
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers Medicines for Europe 12 Oct 2018 Health & Consumers
CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court Medicines for Europe 20 Sep 2018 Health & Consumers

Pages